advertisement

Topcon

Peng C 12

Showing records 1 to 12 | Display all abstracts from Peng C

99197 Bibliometric and visualized analysis of ocular drug delivery from 2001 to 2020
Peng C
Journal of Controlled Release 2022; 345: 625-645
98582 The occurrence timeline of steroid-induced ocular hypertension and cataract in children with systemic autoimmune diseases
Yan H; Tan X
International Ophthalmology 2022; 42: 2175-2184
99197 Bibliometric and visualized analysis of ocular drug delivery from 2001 to 2020
Kuang L
Journal of Controlled Release 2022; 345: 625-645
98582 The occurrence timeline of steroid-induced ocular hypertension and cataract in children with systemic autoimmune diseases
Yu J
International Ophthalmology 2022; 42: 2175-2184
99197 Bibliometric and visualized analysis of ocular drug delivery from 2001 to 2020
Zhao J
Journal of Controlled Release 2022; 345: 625-645
98582 The occurrence timeline of steroid-induced ocular hypertension and cataract in children with systemic autoimmune diseases
Liang T
International Ophthalmology 2022; 42: 2175-2184
99197 Bibliometric and visualized analysis of ocular drug delivery from 2001 to 2020
Ross AE
Journal of Controlled Release 2022; 345: 625-645
98582 The occurrence timeline of steroid-induced ocular hypertension and cataract in children with systemic autoimmune diseases
Liang T; Shi W
International Ophthalmology 2022; 42: 2175-2184
99197 Bibliometric and visualized analysis of ocular drug delivery from 2001 to 2020
Wang Z
Journal of Controlled Release 2022; 345: 625-645
98582 The occurrence timeline of steroid-induced ocular hypertension and cataract in children with systemic autoimmune diseases
Li L
International Ophthalmology 2022; 42: 2175-2184
99197 Bibliometric and visualized analysis of ocular drug delivery from 2001 to 2020
Ciolino JB
Journal of Controlled Release 2022; 345: 625-645
98582 The occurrence timeline of steroid-induced ocular hypertension and cataract in children with systemic autoimmune diseases
Peng C
International Ophthalmology 2022; 42: 2175-2184

Issue 22-4

Change Issue


advertisement

Oculus